Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its CeQur Simplicity insulin delivery device. The company stated that ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果